BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36375315)

  • 21. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma.
    Kreus M; Lehtonen S; Skarp S; Kaarteenaho R
    PLoS One; 2021; 16(4):e0250109. PubMed ID: 33905434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.
    Wendisch D; Dietrich O; Mari T; von Stillfried S; Ibarra IL; Mittermaier M; Mache C; Chua RL; Knoll R; Timm S; Brumhard S; Krammer T; Zauber H; Hiller AL; Pascual-Reguant A; Mothes R; Bülow RD; Schulze J; Leipold AM; Djudjaj S; Erhard F; Geffers R; Pott F; Kazmierski J; Radke J; Pergantis P; Baßler K; Conrad C; Aschenbrenner AC; Sawitzki B; Landthaler M; Wyler E; Horst D; ; Hippenstiel S; Hocke A; Heppner FL; Uhrig A; Garcia C; Machleidt F; Herold S; Elezkurtaj S; Thibeault C; Witzenrath M; Cochain C; Suttorp N; Drosten C; Goffinet C; Kurth F; Schultze JL; Radbruch H; Ochs M; Eils R; Müller-Redetzky H; Hauser AE; Luecken MD; Theis FJ; Conrad C; Wolff T; Boor P; Selbach M; Saliba AE; Sander LE
    Cell; 2021 Dec; 184(26):6243-6261.e27. PubMed ID: 34914922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periostin plays a critical role in the cell cycle in lung fibroblasts.
    Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
    Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
    Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
    Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
    Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
    Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
    Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
    J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.
    Verleden SE; Tanabe N; McDonough JE; Vasilescu DM; Xu F; Wuyts WA; Piloni D; De Sadeleer L; Willems S; Mai C; Hostens J; Cooper JD; Verbeken EK; Verschakelen J; Galban CJ; Van Raemdonck DE; Colby TV; Decramer M; Verleden GM; Kaminski N; Hackett TL; Vanaudenaerde BM; Hogg JC
    Lancet Respir Med; 2020 Jun; 8(6):573-584. PubMed ID: 32061334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.
    Bauer Y; Tedrow J; de Bernard S; Birker-Robaczewska M; Gibson KF; Guardela BJ; Hess P; Klenk A; Lindell KO; Poirey S; Renault B; Rey M; Weber E; Nayler O; Kaminski N
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):217-31. PubMed ID: 25029475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis.
    Heukels P; van Hulst JAC; van Nimwegen M; Boorsma CE; Melgert BN; van den Toorn LM; Boomars KAT; Wijsenbeek MS; Hoogsteden H; von der Thüsen JH; Hendriks RW; Kool M; van den Blink B
    Respir Res; 2018 May; 19(1):90. PubMed ID: 29747640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.
    Wyman AE; Noor Z; Fishelevich R; Lockatell V; Shah NG; Todd NW; Atamas SP
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L945-L958. PubMed ID: 28385812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
    Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
    BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis.
    Lu J; Auduong L; White ES; Yue X
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):106-14. PubMed ID: 23962103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis.
    Gajjala PR; Singh P; Odayar V; Ediga HH; McCormack FX; Madala SK
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.